The Hope Center Lecture is presented at the Annual Hope Center Retreat.

2025 Hope Center Lecture

Tuesday, May 13

Donald Danforth Plant Science Center

Huda Zoghbi, MD

Professor of Molecular and Human Genetics
Baylor College of Medicine

Investigator
Howard Hughes Medical Institute

“Pathogenesis Studies of Neurodegenerative Diseases: From the Rare to the Common”

Short bio

Huda Zoghbi, M.D., is Distinguished Service Professor at Baylor College of Medicine, an Investigator with the Howard Hughes Medical Institute, and founding Director of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital.

Dr. Zoghbi graduated from the American University of Beirut (AUB) and received her medical degree from Meharry Medical College. She joined Baylor College of Medicine for her residency and subsequently obtained postdoctoral research training in molecular genetics.

Dr. Zoghbi’s expertise ranges from neurodevelopment to neurodegeneration. She and Dr. Harry Orr discovered that Spinocerebellar Ataxia type 1 is caused by expansion of a polyglutamine tract. Her subsequent studies demonstrating that CAG expansion leads to accumulation of the mutant protein in neurons has had profound ramifications since many late-onset neurological disorders involve similar accumulations of disease-driving proteins and inspired her studies in Alzheimer disease. Zoghbi and collaborators identified regulators of tau levels providing entry points for development of therapeutics to lower tau. Dr. Zoghbi’s pursuit of the genetic basis of Rett syndrome led to her discovery that mutations in MECP2 cause this postnatal neurological disorder. Her mechanistic studies highlighted the importance of MeCP2 levels for normal brain function. She and her team provided the proof-of-concept data showing that antisense sense oligonucleotide therapy can normalize MeCP2 levels and reverse phnotypes of a MECP2 duplication mouse model.

Dr. Zoghbi has trained over 110 scientists and physician-scientists and is committeed to educating the next generation. She has been elected to the National Academy of Medicine, the National Academy of Sciences, and the American Academy of Arts and Sciences. Dr. Zoghbi’s honors include the Breakthrough Prize in Life Sciences; the Canada Gairdner International Prize; the Lundbeck Foundation’s 2020 Brain Prize; the Kavli Prize, and most recently the August M. Watanabe Prize in Translational Research.

Hope Center Lectures

2024: Joseph Lewcock, PhD (Denali Therapeutics)

2023: Michael Ward, MD, PhD (National Institute of Neurological Disorders & Stroke/National Institutes of Health)

2022: Louise Rodino-Klapac, PhD (Sarepta Therapeutics, Inc.), Martin Kampmann, PhD (University of California, San Francisco)

2021: Merit Cudkowicz (Harvard Medical School/Massachusetts General Hospital)

2019: Guoping Feng (Massachusetts Institute of Technology), Sally Temple (Neural Stem Cell Institute)

2018: Leonard Petrucelli, PhD (Mayo Clinic Florida)

2017: Laura Ranum (University of Florida)

2016: Beverly Davidson (University of Pennsylvania)

2015: Daria Mochly-Rosen (Stanford University)

2014: Al Sandrock (Biogen Idec)

2013: Ryan Watts (Genentech)

2012: David Julius (University of California, San Francisco)

2011: Jeffery Kelly (The Scripps Research Institute)

2010: Harry Orr (University of Minnesota)

2009: Marc Tessier-Lavigne (Genentech)

2008: Ben Barres (Stanford University)

2007: Steve Wagner (TorreyPines Therapeutics)